Metabolic syndrome and its components as predictors of incident type 2 diabetes mellitus in an Aboriginal community

CMAJ. Canadian Medical Association Journal

Volumn 180, Issue 6, 2009, Pages 617-624

  Ley, Sylvia H ^a   Harris, Stewart B ^b   Mamakeesick, Mary ^c   Noon, Tina ^c   Fiddler, Edith ^c   Gittelsohn, Joel ^d   Wolever, Thomas M S ^a   Connelly, Philip W ^e,f   Hegele, Robert A ^g   Zinman, Bernard ^a,h   Hanley, Anthony J G ^a,h  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c Sandy Lake Health and Diabetes Project   (Canada)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

^f ST MICHAEL'S HOSPITAL   (Canada)

^g ROBARTS RESEARCH INSTITUTE   (Canada)

^h MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABORIGINE; ADIPOSE TISSUE; ARTICLE; BLOOD PRESSURE; CANADA; DIAGNOSTIC ACCURACY; ETHNIC GROUP; GLUCOSE BLOOD LEVEL; HYPERLIPIDEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; INSULIN BLOOD LEVEL; METABOLIC SYNDROME X; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREDICTION; RISK FACTOR; SYNDROME DELINEATION;

EID: 62649147949     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.080972     Document Type: Article

References (35)

1. Young TK, Reading J, Elias B, et al. Type 2 diabetes mellitus in Canada's First Nations: status of an epidemic in progress. CMAJ 2000;163:561-6.
2. Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet2005:365:1333-46.
3. National Cholesterol Education Program. Executive summary of the third report of the National Cholesterol Education Program fNCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel 111). JAMA 2001;285:2486-97.
4. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. Brussels (Belgium): International Diabetes Federation; 2005.
5. International Diabetes Federation. The IDF consensus definition of the metabolic syndrome in children and adolescents. Brussels (Belgium): International Diabetes Federation; 2007.
6. Gale EAM. Should we dump the metabolic syndrome? Yes. BMJ 2008;336:640.
7. Alberti KGMM, Zimmet PZ. Should we dump the metabolic syndrome? No. BMJ 200S;336:641.
8. Lorenzo C, Williams K, Hunt KJ, et al. The National Cholesterol Education Program-Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care 2007;30:8-13.
9. Wilson PWF, D' Agostino RB, Parise H, et al. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005;112:3066-72.
10. Resnick HE, Jones K, Ruotolo G, et al. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiaberic American Indians: the Strong Heart Study. Diabetes Care 2003;26:861-7.
11. Harris SB, Gittelsohn J, Hanley A, et al. The prevalence of N1DDM and associated risk factors in Native Canadians. Diabetes Care 1997;20:185-7.
12. Harris SB, Zinman B, Hanley A, et al. The impact of diabetes on cardiovascular risk factors and outcomes in a native Canadian population. Diabetes Res Clin Pract 2002;55:165-73.
13. Liu J, Young TK, Zinman B, et al. Lifestyle variables, non-traditional cardiovascular risk factors, and the metabolic syndrome in an Aboriginal Canadian population. Obesity (Silver Spring) 2006;14:500-8.
14. Green C, Blanchard JF, Young TK, et al. The epidemiology of diabetes in the Manitoba-registered First Nation population: current patterns and comparative trends. Diabetes Care 20G3;26:1993-8.
15. Horn OK, Jacobs-Whyte H, lng A, et al. Incidence and prevalence of type 2 diabetes in the First Nation community of Kahnawa:ke, Quebec, Canada, 1986-2003. Can J Public Health 2007;98:438-43.
16. Hegele RA, Zinman B, Hanley AJG, et al. Genes, environment and Oji-Cree type 2 diabetes. Clin Biochem 2003;36:163-70.
17. Hanley AJ, Harris SB, Bamie A, et al. The Sandy Lake Health and Diabetes Project: design, methods and lessons learned. Chronic Dis Can 1995;16:149-56.
18. World Health Organization. Definition, diagnosis, and classification of diabetes mellitus and its complications: report of a WHO consultation. Geneva (Switzerland): World Health Organization; 1999.
19. Lipid Research Clinics Program. Manual of laboratory operations. Washington (DC): US Government Printing Office; 1984. p. 1-81. NTH publ. no. 75-6282.
20. Fernandez JR. Redden DT, Pietrobelli A, et al. Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr 2004:145:439-44.
21. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonpararnetric approach. Biometrics 1988;44:837-45.
22. Lee ET, Howard BY, Savage PJ, et al. Diabetes and impaired glucose tolerance in three American Indian populations aged 45-74 years. The Strong Heart Study. Diabetes Care 1995;18:599-610.
23. Resnick HE. Metabolic syndrome in American Indians. Diabetes Care 2002;25: 1246-7.
24. Russell M, de Simone G, Resnick HE, et al. The metabolic syndrome in American Indians: the Strong Heart Study. J Cardiometab Syndr 2007;2:283-7.
25. Festa A, D' Agostino R Jr, Hanley AJG, et al. Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose. Diabetes 2004;53:1549-55.
26. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-50.
27. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002:346: 393-403.
28. Diabetes Prevention Program Research Group. The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care 2002;25:2165-71.
29. Stem MP, Williams K, Haffner SM. Identification of persons at high risk for type 2 diabetes mellitus: Do we need the oral glucose tolerance test? Ann Intern Med 2002;136:575-81.
30. Stem MP, Fatehi P, Williams K, et al. Predicting future cardiovascular disease: Do we need the oral glucose tolerance test? Diabetes Care 2002;25:1851-6.
31. Shall BR, Hus. JE, Zinman B. Increasing rates of ischemic heart disease in the Native population of Ontario, Canada. Arch Intern Med 2000; 160:1862-6.
32. Orchard TJ, Temprosa M, Goldberg R, et al. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann Intern Med 2005; 142:611-9.
33. Bo S, Ciccone G, Baldi C, et al. Effectiveness of a lifestyle intervention on metabolic syndrome. A randomized controlled trial. J Gen Intern Med 2007;22:1695- 703.
34. Ilanne-Parikka P, Eriksson JG, Lindstrom J, et al. Effect of lifestyle intervention on the occurrence of metabolic syndrome and its components in the Finnish Diabetes Prevention Study. Diabetes Care 2008;31:805-7.
35. Young HC, Change C. The Indian experience in the Central Subarctic. Toronto (ON): University of Toronto Press; 1988.